Robyn Ast-Gmoser, Attorney, Polsinelli to Speak at the Knowledge Group’s Event
New York, NY, November 07, 2017 --(PR.com)-- The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Robyn Ast-Gmoser, Attorney, Polsinelli will speak at the Knowledge Group’s webcast entitled: “Paragraph IV Patent Certifications: Recent Legal and Regulatory Developments Live Webcast.” This event is scheduled for Thursday, November 16, 2017 @ 12:00 PM to 2:00 PM (ET).
For further details, please visit: https://theknowledgegroup.org/event-homepage/?event_id=2779
About Robyn Ast-Gmoser
Robyn Ast-Gmoser represents clients in all aspects of patent and trademark litigation, including initial case assessment and strategy development, fact and expert evidentiary case development, claim construction and dispositive motions practice, and trial. An experienced patent litigator, Robyn manages cases from start to finish, including overseeing all phases of discovery, regularly participating in the taking and defending of depositions, and preparing and arguing contested motions. Robyn’s practice has a particular focus on Hatch-Waxman paragraph IV litigation on behalf of pharmaceutical clients for products in a variety of dosage forms.
In addition to litigation, Robyn’s practice also involves counseling clients during new product development to help clients make informed decisions about product development and launch. Robyn further counsels clients contemplating agreements or settlements involving intellectual property licenses or transfer. She is a patent attorney admitted to practice before the U.S. Patent and Trademark Office, and brings to bear on behalf of clients a command of the patenting process to achieve a client’s desired results.
About Polsinelli
Polsinelli is an Am Law 100 firm with approximately 800 attorneys in 20 offices, serving corporations, institutions, and entrepreneurs nationally. Ranked #17* for Client Service Excellence among 650 U.S. law firms, Polsinelli has risen more than 50 spots in Am Law's annual firm ranking over the past five years. Polsinelli attorneys provide practical legal counsel infused with business insight, and focus on health care, financial services, real estate, intellectual property, mid-market corporate, labor and employment, and business litigation. Polsinelli attorneys have depth of experience in 100 service areas and 70 industries.
Event Synopsis:
The Paragraph IV Patent Certification landscape is under an evolving and transformative backdrop. With more than $125 billion patent losses in 2016, the stakes for pharmaceutical companies are higher. Complacency is off the table. Businesses should keep themselves abreast of the recent legal and regulatory developments concerning Paragraph IV Patent Certifications to better position themselves amidst the risks.
In this live webcast, a panel of distinguished professionals and thought leaders assembled by The Knowledge Group will help drug companies understand the significant aspects of this topic. They will provide an in-depth discussion of recent Paragraph IV Patent Certification developments and trends. Speakers will also offer best application practices while ensuring compliance with applicable laws.
Key topics include:
Paragraph IV Patent Certification – Overview
The FDA Draft Guidance on 180-Day Exclusivity for Generics
Paragraph IV Patent Certification – Notable Cases
Sanofi v. Lupin Atlantis Holdings SA
Par Pharmaceutical, Inc. v. Luitpold Pharmaceuticals, Inc.
Best Application and Compliance Practices
About The Knowledge Group/The Knowledge Congress Live Webcast Series
The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register for an event, please visit: http://theknowledgegroup.org/
For further details, please visit: https://theknowledgegroup.org/event-homepage/?event_id=2779
About Robyn Ast-Gmoser
Robyn Ast-Gmoser represents clients in all aspects of patent and trademark litigation, including initial case assessment and strategy development, fact and expert evidentiary case development, claim construction and dispositive motions practice, and trial. An experienced patent litigator, Robyn manages cases from start to finish, including overseeing all phases of discovery, regularly participating in the taking and defending of depositions, and preparing and arguing contested motions. Robyn’s practice has a particular focus on Hatch-Waxman paragraph IV litigation on behalf of pharmaceutical clients for products in a variety of dosage forms.
In addition to litigation, Robyn’s practice also involves counseling clients during new product development to help clients make informed decisions about product development and launch. Robyn further counsels clients contemplating agreements or settlements involving intellectual property licenses or transfer. She is a patent attorney admitted to practice before the U.S. Patent and Trademark Office, and brings to bear on behalf of clients a command of the patenting process to achieve a client’s desired results.
About Polsinelli
Polsinelli is an Am Law 100 firm with approximately 800 attorneys in 20 offices, serving corporations, institutions, and entrepreneurs nationally. Ranked #17* for Client Service Excellence among 650 U.S. law firms, Polsinelli has risen more than 50 spots in Am Law's annual firm ranking over the past five years. Polsinelli attorneys provide practical legal counsel infused with business insight, and focus on health care, financial services, real estate, intellectual property, mid-market corporate, labor and employment, and business litigation. Polsinelli attorneys have depth of experience in 100 service areas and 70 industries.
Event Synopsis:
The Paragraph IV Patent Certification landscape is under an evolving and transformative backdrop. With more than $125 billion patent losses in 2016, the stakes for pharmaceutical companies are higher. Complacency is off the table. Businesses should keep themselves abreast of the recent legal and regulatory developments concerning Paragraph IV Patent Certifications to better position themselves amidst the risks.
In this live webcast, a panel of distinguished professionals and thought leaders assembled by The Knowledge Group will help drug companies understand the significant aspects of this topic. They will provide an in-depth discussion of recent Paragraph IV Patent Certification developments and trends. Speakers will also offer best application practices while ensuring compliance with applicable laws.
Key topics include:
Paragraph IV Patent Certification – Overview
The FDA Draft Guidance on 180-Day Exclusivity for Generics
Paragraph IV Patent Certification – Notable Cases
Sanofi v. Lupin Atlantis Holdings SA
Par Pharmaceutical, Inc. v. Luitpold Pharmaceuticals, Inc.
Best Application and Compliance Practices
About The Knowledge Group/The Knowledge Congress Live Webcast Series
The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register for an event, please visit: http://theknowledgegroup.org/
Contact
The Knowledge Group
Thomas LaPointe, Jr., Executive Director
646-844-0200
www.theknowledgegroup.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Thomas LaPointe, Jr., Executive Director
646-844-0200
www.theknowledgegroup.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Contact
Categories